The bioSimilia is an initiative to bring the benefits of ultra-minute nano-pharmacological substances to alleviate many disease conditions. Eminent physician cum researcher Dr Rajesh Shah, MD, has been currently working on researching COVID-19 Nosode. BiosimCovex is a COVID-19 Nosode. We scientifically prepared three variants of COVID-19 Nosode at Mumbai’s Haffkine Institute and Gujarat University . They have undergone pre-clinical and clinical evaluation. Scientific information and research findings of the COVID-19 Nosode are shared on this website.

Initial studies with the COVID-19 Nosode (BiosimCovex) have shown encouraging results. And, further studies are underway. We have submitted our proposal for Emergency Approval to the Government of India, Ministry of Health and Family Welfare. BiosimCovex is currently undergoing a review process by various regulatory agencies.